Glucksmann at the helm at Sensorium

Sensorium Therapeutics Inc. named Alexandra “Sandra” Glucksmann president and CEO, succeeding Dick Simon. Simon, a co-founder of the neuroscience company, will become an adviser while remaining on the board. Glucksmann was the founding president and CEO of Cedilla Therapeutics Inc., before which she was the founding COO of Editas Medicine Inc. (NASDAQ:EDIT).

Theseus Pharmaceuticals Inc. (NASDAQ:THRX) is terminating President and CEO Timothy Clackson and CMO David Kerstein, effective Dec. 7, as part of a workforce reduction. Theseus named CFO Bradford Dahms president and a director. The company dropped its lead KIT program in July. ...